Global Viscosupplementation Market Analysis 2017 - Forecast to 2022

  • ID: 4301738
  • Report
  • Region: Global
  • 182 pages
  • Hoovers Research
1 of 4

FEATURED COMPANIES

  • Allergan, Inc
  • Croma-Pharma GmbH
  • Fidia Farmaceutici SpA
  • Hyaltech Ltd.
  • Nordic Drugs
  • Seikagaku Corporation
  • MORE
The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Viscosupplementation". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2014 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
  • Market Sizing estimations and forecasts for 6 years across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities,)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Inc
  • Croma-Pharma GmbH
  • Fidia Farmaceutici SpA
  • Hyaltech Ltd.
  • Nordic Drugs
  • Seikagaku Corporation
  • MORE
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Viscosupplementation Market by Product
5.1 Introduction
5.2 Single-Injection Cycle
5.3 Three-Injection Cycle
5.4 Five-Injection Cycle

6 Viscosupplementation Market by Anatomy
6.1 Introduction
6.2 Ankle Osteoarthritis
6.3 Knee Osteoarthritis
6.4 Hip Osteoarthritis
6.5 Shoulder Osteoarthritis

7 Viscosupplementation Market by End User
7.1 Introduction
7.2 Ambulatory Surgical Centres
7.3 Hospitals
7.4 Orthopaedic Clinics

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Croma-Pharma GmbH
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Allergan, Inc
10.3 Anika Therapeutics, Inc
10.4 F. Hoffmann-La Roche Ltd
10.5 Ferring Pharmaceuticals, Inc
10.6 Fidia Farmaceutici SpA
10.7 GALDERMA S.A
10.8 Hyaltech Ltd.
10.9 LifeCore Biomedical LLC
10.10 Nordic Drugs
10.11 Sanofi Aventis LLC
10.12 Seikagaku Corporation
10.13 Shandong Freda Biochem
10.14 Shanghai Jingfeng Pharmaceutical
10.15 TEIJIN PHARMA

11 Appendix

12 Disclaimer

List of Tables
Table 1 Global Viscosupplementation Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Viscosupplementation Market Analysis, by Product, 2013-2022 ($MN)
Table 3 Global Viscosupplementation Market Analysis, by Single-Injection Cycle, 2013-2022 ($MN)
Table 4 Global Viscosupplementation Market Analysis, by Three-Injection Cycle, 2013-2022 ($MN)
Table 5 Global Viscosupplementation Market Analysis, by Five-Injection Cycle, 2013-2022 ($MN)
Table 6 Global Viscosupplementation Market Analysis, by Anatomy, 2013-2022 ($MN)
Table 7 Global Viscosupplementation Market Analysis, by Ankle Osteoarthritis, 2013-2022 ($MN)
Table 8 Global Viscosupplementation Market Analysis, by Knee Osteoarthritis, 2013-2022 ($MN)
Table 9 Global Viscosupplementation Market Analysis, by Hip Osteoarthritis, 2013-2022 ($MN)
Table 10 Global Viscosupplementation Market Analysis, by Shoulder Osteoarthritis, 2013-2022 ($MN)
Table 11 Global Viscosupplementation Market Analysis, by End User, 2013-2022 ($MN)
Table 12 Global Viscosupplementation Market Analysis, by Ambulatory Surgical Centres, 2013-2022 ($MN)
Table 13 Global Viscosupplementation Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 14 Global Viscosupplementation Market Analysis, by Orthopaedic Clinics, 2013-2022 ($MN)
Table 15 North America Viscosupplementation Market Analysis, by Country, 2013-2022 ($MN)
Table 16 North America Viscosupplementation Market Analysis, by Product, 2013-2022 ($MN)
Table 17 North America Viscosupplementation Market Analysis, by Single-Injection Cycle, 2013-2022 ($MN)
Table 18 North America Viscosupplementation Market Analysis, by Three-Injection Cycle, 2013-2022 ($MN)
Table 19 North America Viscosupplementation Market Analysis, by Five-Injection Cycle, 2013-2022 ($MN)
Table 20 North America Viscosupplementation Market Analysis, by Anatomy, 2013-2022 ($MN)
Table 21 North America Viscosupplementation Market Analysis, by Ankle Osteoarthritis, 2013-2022 ($MN)
Table 22 North America Viscosupplementation Market Analysis, by Knee Osteoarthritis, 2013-2022 ($MN)
Table 23 North America Viscosupplementation Market Analysis, by Hip Osteoarthritis, 2013-2022 ($MN)
Table 24 North America Viscosupplementation Market Analysis, by Shoulder Osteoarthritis, 2013-2022 ($MN)
Table 25 North America Viscosupplementation Market Analysis, by End User, 2013-2022 ($MN)
Table 26 North America Viscosupplementation Market Analysis, by Ambulatory Surgical Centres, 2013-2022 ($MN)
Table 27 North America Viscosupplementation Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 28 North America Viscosupplementation Market Analysis, by Orthopaedic Clinics, 2013-2022 ($MN)
Table 29 Europe Viscosupplementation Market Analysis, by Country, 2013-2022 ($MN)
Table 30 Europe Viscosupplementation Market Analysis, by Product, 2013-2022 ($MN)
Table 31 Europe Viscosupplementation Market Analysis, by Single-Injection Cycle, 2013-2022 ($MN)
Table 32 Europe Viscosupplementation Market Analysis, by Three-Injection Cycle, 2013-2022 ($MN)
Table 33 Europe Viscosupplementation Market Analysis, by Five-Injection Cycle, 2013-2022 ($MN)
Table 34 Europe Viscosupplementation Market Analysis, by Anatomy, 2013-2022 ($MN)
Table 35 Europe Viscosupplementation Market Analysis, by Ankle Osteoarthritis, 2013-2022 ($MN)
Table 36 Europe Viscosupplementation Market Analysis, by Knee Osteoarthritis, 2013-2022 ($MN)
Table 37 Europe Viscosupplementation Market Analysis, by Hip Osteoarthritis, 2013-2022 ($MN)
Table 38 Europe Viscosupplementation Market Analysis, by Shoulder Osteoarthritis, 2013-2022 ($MN)
Table 39 Europe Viscosupplementation Market Analysis, by End User, 2013-2022 ($MN)
Table 40 Europe Viscosupplementation Market Analysis, by Ambulatory Surgical Centres, 2013-2022 ($MN)
Table 41 Europe Viscosupplementation Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 42 Europe Viscosupplementation Market Analysis, by Orthopaedic Clinics, 2013-2022 ($MN)
Table 43 Asia Pacific Viscosupplementation Market Analysis, by Country, 2013-2022 ($MN)
Table 44 Asia Pacific Viscosupplementation Market Analysis, by Product, 2013-2022 ($MN)
Table 45 Asia Pacific Viscosupplementation Market Analysis, by Single-Injection Cycle, 2013-2022 ($MN)
Table 46 Asia Pacific Viscosupplementation Market Analysis, by Three-Injection Cycle, 2013-2022 ($MN)
Table 47 Asia Pacific Viscosupplementation Market Analysis, by Five-Injection Cycle, 2013-2022 ($MN)
Table 48 Asia Pacific Viscosupplementation Market Analysis, by Anatomy, 2013-2022 ($MN)
Table 49 Asia Pacific Viscosupplementation Market Analysis, by Ankle Osteoarthritis, 2013-2022 ($MN)
Table 50 Asia Pacific Viscosupplementation Market Analysis, by Knee Osteoarthritis, 2013-2022 ($MN)
Table 51 Asia Pacific Viscosupplementation Market Analysis, by Hip Osteoarthritis, 2013-2022 ($MN)
Table 52 Asia Pacific Viscosupplementation Market Analysis, by Shoulder Osteoarthritis, 2013-2022 ($MN)
Table 53 Asia Pacific Viscosupplementation Market Analysis, by End User, 2013-2022 ($MN)
Table 54 Asia Pacific Viscosupplementation Market Analysis, by Ambulatory Surgical Centres, 2013-2022 ($MN)
Table 55 Asia Pacific Viscosupplementation Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 56 Asia Pacific Viscosupplementation Market Analysis, by Orthopaedic Clinics, 2013-2022 ($MN)
Table 57 RoW Viscosupplementation Market Analysis, by Country, 2013-2022 ($MN)
Table 58 RoW Viscosupplementation Market Analysis, by Product, 2013-2022 ($MN)
Table 59 RoW Viscosupplementation Market Analysis, by Single-Injection Cycle, 2013-2022 ($MN)
Table 60 RoW Viscosupplementation Market Analysis, by Three-Injection Cycle, 2013-2022 ($MN)
Table 61 RoW Viscosupplementation Market Analysis, by Five-Injection Cycle, 2013-2022 ($MN)
Table 62 RoW Viscosupplementation Market Analysis, by Anatomy, 2013-2022 ($MN)
Table 63 RoW Viscosupplementation Market Analysis, by Ankle Osteoarthritis, 2013-2022 ($MN)
Table 64 RoW Viscosupplementation Market Analysis, by Knee Osteoarthritis, 2013-2022 ($MN)
Table 65 RoW Viscosupplementation Market Analysis, by Hip Osteoarthritis, 2013-2022 ($MN)
Table 66 RoW Viscosupplementation Market Analysis, by Shoulder Osteoarthritis, 2013-2022 ($MN)
Table 67 RoW Viscosupplementation Market Analysis, by End User, 2013-2022 ($MN)
Table 68 RoW Viscosupplementation Market Analysis, by Ambulatory Surgical Centres, 2013-2022 ($MN)
Table 69 RoW Viscosupplementation Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 70 RoW Viscosupplementation Market Analysis, by Orthopaedic Clinics, 2013-2022 ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan, Inc
  • Anika Therapeutics, Inc
  • Croma-Pharma GmbH
  • F. Hoffmann-La Roche Ltd
  • Ferring Pharmaceuticals, Inc
  • Fidia Farmaceutici SpA
  • GALDERMA S.A
  • Hyaltech Ltd.
  • LifeCore Biomedical LLC
  • Nordic Drugs
  • Sanofi Aventis LLC
  • Seikagaku Corporation
  • Shandong Freda Biochem
  • Shanghai Jingfeng Pharmaceutical
  • TEIJIN PHARMA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll